YBX1 and cancer: By acting as a core component of the regulatory loop, ILK promotes the aggressive and metastatic phenotype of cancer cells in a hypoxic setting through multiple oncogenic signaling pathways, including those mediated by Akt, GSK3β, and YB-1 (Figure 7D).